Publications en collaboration avec des chercheurs de Instituto de Investigación Sanitaria Valdecilla (16)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  2. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211

  3. Sudden Hearing Loss as an Initial Symptom of Vestibular Schwannoma

    World Neurosurgery, Vol. 185, pp. e549-e554

  4. Sudden hearing loss secondary to syphilis

    American Journal of Otolaryngology - Head and Neck Medicine and Surgery, Vol. 45, Núm. 3

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Circulating miRNAs signature on breast cancer: the MCC-Spain project

    European Journal of Medical Research, Vol. 28, Núm. 1

  3. Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 10, pp. 1208-1217

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  2. Prevalence and temporal evolution of asthma symptoms in Spain. Global Asthma Network (GAN) study

    Anales de Pediatria, Vol. 97, Núm. 3, pp. 161-171

  3. Severity of COVID-19 attributable to obesity according to BMI and CUN-BAE

    Semergen, Vol. 48, Núm. 8, pp. 6

  4. Sleep and breast and prostate cancer risk in the MCC-Spain study

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study

    Scientific reports, Vol. 11, Núm. 1, pp. 5375

  2. Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry

    Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616

2017

  1. Colorectal cancer and long-term exposure to trihalomethanes in drinking water: A multicenter case-control study in Spain and Italy

    Environmental Health Perspectives, Vol. 125, Núm. 1, pp. 56-65

2016

  1. Breast cancer risk and night shift work in a case–control study in a Spanish population

    European Journal of Epidemiology, Vol. 31, Núm. 9, pp. 867-878